COR2ED The Heart of Medical Education
Our COR2ED channel brings together world-renowned medical experts to discuss and provide clear guidance on the latest scientific and clinical insights in various therapeutic areas, including oncology, cardiology, hemostasis, rare diseases, hemato-oncology, and endocrinology. At COR2ED, we are committed to providing balanced and evidence-based independent medical education to support healthcare ...
read more ↘ professionals in enhancing patient care. Many of our videos are created in collaboration with medical societies and patient advocacy groups.
↖ read less
read more ↘ professionals in enhancing patient care. Many of our videos are created in collaboration with medical societies and patient advocacy groups.
↖ read less
Playback speed
10 seconds
Current and Upcoming Treatment Strategies for ER+/HER2- Advanced BC
101 views
June 4, 2024
In this conference update video, Prof. Valentina Guarneri, Prof. Matteo Lambertini, and Prof. Federico Rojo summarise the key points presented at the highly anticipated EBCC-14 Industry Satellite Symposium and review the current and future treatment landscape for ER+/HER2- advanced breast cancer, with a focus on the metastatic luminal subtype.
Topics of discussion include:
- Overview of the ESMO metastatic breast cancer living guidelines
- Impact of endocrine resistance and sensitivity
- The benefit of biomarker-selected endocrine-based therapies in ER+/HER2- advanced breast cancer
- ESR1 mutation: clinical significance and testing strategies
Visit the COR2ED website to download the free accompanying slide set or to watch more videos.
Topics of discussion include:
- Overview of the ESMO metastatic breast cancer living guidelines
- Impact of endocrine resistance and sensitivity
- The benefit of biomarker-selected endocrine-based therapies in ER+/HER2- advanced breast cancer
- ESR1 mutation: clinical significance and testing strategies
Visit the COR2ED website to download the free accompanying slide set or to watch more videos.
Comments 0
Login to view comments.
Click here to Login
Oncology